Impact of ASHP Drug Diversion Guidelines on Data and Surveillance featuring ASHP Guideline Co-authors

In this episode, co-authors of the recently released ASHP Guidelines on Preventing Diversion of Controlled Substances will discuss the changes to these guidelines as they impact data use and surveillance in the acute and non-acute care settings.  They will share the updates to the guidelines and focus on the impact on data use for ongoing surveillance.  Additionally, they will discuss the unique challenges of drug diversion prevention outside of acute care settings.


Amanda Hays, PharmD., MHA, BCPS, CPHQ, DPLA, FASHP
Director, Medical Affairs, BD


Eric Maroyka, PharmD, BCPS
Senior Director, Center Pharmacy Practice Advancement, ASHP
Jordan Rush, PharmD, MS
Director, System Retail & Outpatient Pharmacy, UNC Health
Co-author, ASHP Revised Guidelines, Controlled Substance Diversion
Kristi Gullickson, PharmD, MBA, FASHP, FMSHP, DLPA
Director, Pharmacy and System Operations Lead, Allina Health at Abbot Northwestern Hospital
Co-author, ASHP Revised Guidelines, Controlled Substance Diversion


CHIME Opioid Action Center

710 Avis Drive, Suite 200
Ann Arbor, MI 48108


Phone: 1.734.665.0000


Questions, comments? Submit your feedback below!

  • This field is for validation purposes and should be left unchanged.